Thrombospondin 1 expression and angiogenesis in breast carcinoma and their relation with platelet activity

References

• Ellis IO, Schnitt SJ, Sastre-Garau X, Bussolati G, Tavassoli FA, Eusebi V, . Invasive breast carcinoma. World Health Organization classification of tumours: pathology and genetics of tumours of the breast and female genital organs, FA Tavassoli, P Devilee, et al. IARC Press, Lyon 2003; 13–60
   Google Scholar
• Elston CW, Ellis IO. Classification of malignant breast disease. The breast, systemic pathology3rd edn, CW Elston, IO Ellis. Churchill Livingstone, Edinburgh 1998; 239–47
   Google Scholar
• Tavassoli FA. General considerations. Pathology of the breast2nd edn, FA Tavassoli. Appleton and Lange, Hong Kong 1999; 27–74
   Google Scholar
• Kumar V, Abbas AK, Fausto N. Tissue Renewal and Repair: Regeneration, Healing, and Fibrosis. Robbins Pathologic Basis of Disease7th edn, V Kumar, AK Abbas, N Fausto. Elsevier Saunders, China 2005; 87–118
   Google Scholar
• Campbell SC, Volpert OV, Ivanovich M, Bouck NP. Molecular mediators of angiogenesis in bladder cancer. Cancer Res. 1998; 58: 1298–304
   PubMed Web of Science ®Google Scholar
• Grant SW, Kysthoobayeva AS, Kurosaki T, Jakowatz J, Fruehauf JP. Mutant p53 correlates with reduced expression of thrombospondin-1, increased angiogenesis, and metastatic progression in melanoma. Cancer Detect Prev. 1998; 22: 185–94
   PubMedGoogle Scholar
• Kawahara N, Ono M, Taguchi K, Okamoto M, Shimada M, Takenaka K, et al. Enhanced expression of thrombospondin-1 and hypovascularity in human cholangiocarcinoma. Hepatology. 1998; 28: 1512–7
   PubMed Web of Science ®Google Scholar
• Volm M, Koomagi R, Mattern J. Angiogenesis and cigarette smoking in squamous cell lung carcinomas: an immunohistochemical study of 28 cases. Anticancer Res. 1999; 19: 333–6
   PubMed Web of Science ®Google Scholar
• Byrne GJ, Hayden KE, McDowell G, Lang H, Kirwan CC, Tetlow L, et al. Angiogenic characteristics of circulating and tumoral thrombospondin-1 in breast cancer. Int J Oncol. 2007; 31: 1127–32
   PubMedGoogle Scholar
• Packham MA, Mustard JF. Platelet adhesion. Prog Hemos Thromb. 1984; 7: 211–88
   PubMedGoogle Scholar
• Mehta P. Potential role of platelets in the pathogenesis of tumor metastasis. Blood. 1984; 63: 55–63
   PubMedGoogle Scholar
• Ersöz G, Yakaryilmaz A, Zergero(lu AM. The effect of acute submaximal exercise on platelet aggregation in different menstruel phases in women. Thromb Res. 2003; 108: 147–50
   Google Scholar
• Brune B, Ullrich V. Different calcium pools in human platelets and their role in thromboxane A2 formation. J Biol Chem. 1991; 266: 19232–7
   PubMed Web of Science ®Google Scholar
• Pistono M, Bergerone S, Carrieri L, Paglia I, Stefano D, Caprizzi A, et al. Platelet cyclic GMP levels in unstable angina and myocardial infarction. Platelets. 2002; 13: 307–11
   PubMed Web of Science ®Google Scholar
• Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991; 19: 403–10
   PubMed Web of Science ®Google Scholar
• Weidner N, Semple JP, Welch WR, Folkman J. Tumour angiogenesis and metastases- correlation in invasive breast carcinoma. N Engl J Med. 1991; 324: 1–8
   PubMed Web of Science ®Google Scholar
• Bosari S, Lee AK, DeLellis RA, Wiley BD, Heatley GJ, Silverman ML. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol. 1992; 23: 755–61
   PubMed Web of Science ®Google Scholar
• Battifora H, Mehta P, Ahn C, Esteban JM. Estrogen receptor immunohistochemical assay in paraffin-embedded tissue. A better gold standard?. Appl Immunohistochem. 1993; 1: 39–45
   Google Scholar
• Folkman JJ. What is the evidence that tumours are angiogenesis dependent?. J Natl Cancer Inst. 1990; 82: 4–6
   PubMed Web of Science ®Google Scholar
• Valentino LA, Ladisch S. Circulating tumour gangliosides enhance platelet activation. Blood. 1994; 83: 2872–7
   PubMed Web of Science ®Google Scholar
• Cox G, Walker RA, Andi A, Steward WP, O'Byrne KJ. Prognostic significance of platelet and microvessel counts in operabl non-small cell lung cancer. Lung Cancer. 2000; 29: 169–77
   PubMed Web of Science ®Google Scholar
• Pedersen LM, Milman N. Prognostic significance of thyrombocytosis in patients with primary lung cancer. Eur Respir J. 1996; 9: 1826–30
   PubMed Web of Science ®Google Scholar
• Gucer F, Moser F, Tamussino K, Reich O, Haas J, Arikan G, et al. Thrombocytosis as a prognostic factor in endometrial carcinoma. Gynecol Oncol. 1998; 70: 210–4
   PubMed Web of Science ®Google Scholar
• O'Byrne KJ, Dobbs N, Propper D, Smith K, Harris AL. Vascular endothelial growth factor, platelet counts, and prognosis in renal cancer. Lancet. 1999; 353: 1494–5
   PubMed Web of Science ®Google Scholar
• Pinedo HM, Verheul HMW, D'Amato RJ, Folkman J. Involvement of platelets in tumour angiogenesis?. Lancet. 1998; 352: 1775–7
   PubMed Web of Science ®Google Scholar
• Jurasz P, Alonso-Escolano D, Rodomski MW. Platelet–cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation. Br J Pharmacol. 2002; 143: 819–26
   Google Scholar
• Griffith OW, Stuehr DJ. Nitric oxide synthases: properties and catalytic mechanism. Annu Rev Physiol. 1995; 57: 707–36
   PubMed Web of Science ®Google Scholar
• Dishy V, Harris PA, Pierce R, Prasad HC, Sowowara G, Boner HL, et al. Sildenafil does not improve nitric oxide-mediated endothelium-dependent vascular responses in smokers. Br J Clin Pharmacol. 2003; 57: 209–12
   Google Scholar
• Waldman SA, Murad F. Cyclic GMP synthesis and function. Pharmacol Rev. 1987; 39: 163–96
   PubMed Web of Science ®Google Scholar
• Di Nicola M, Santoleri F, Soscia S, Fioroni M, Rubini C, Piattelli A, et al. Cyclic guanosine monophosphate role in human carcinoma pathogenesis. Nucleosides Nucleotides Nucleic Acids. 2004; 23: 1555–8
   PubMed Web of Science ®Google Scholar
• Israeli E, Raz B, Kerner H, Barzilai D. Cyclic nucleotide levels in human breast cancer and in rat mammary tissues during tumour development. Breast Cancer Res Treat. 1985; 6: 241–8
   PubMedGoogle Scholar
• Chaimoff C, Malachi T, Halbrecht I. Prostaglandin E2 and cyclic nucleotides in plasma and urine of colonic cancer patients. J Cancer Res Clin Oncol. 1985; 110: 153–6
   PubMedGoogle Scholar
• Gallo O, Sardi I, Masini M, Franchi A. Re: Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer. J Natl Cancer Inst. 1999; 91: 1509–11
   PubMedGoogle Scholar
• Bornstein P. Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin-1. J Cell Biol. 1995; 130: 503–6
   PubMed Web of Science ®Google Scholar
• Bornstein P, Stage EH. Thrombospondins. Methods Enzymol. 1994; 245: 62–85
   PubMed Web of Science ®Google Scholar
• Baenziger NL, Brodie GN, Majerus PW. Isolation and properties of a thrombin sensitive protein of human platelets. J Biol Chem. 1972; 247: 2723–31
   PubMed Web of Science ®Google Scholar
• Tuszynski GP, Smith M, Rothman VL, Capuzzi DM, Joseph RR, Katz J, et al. Thrombospondin levels in patients with malignancy. Thromb Haemost. 1992; 67: 607–11
   PubMed Web of Science ®Google Scholar
• Yamashita Y, Kurohiji T, Tuszynski GP, Sakai T, Shirakusa T. Plasma thrombospondin levels in patients with colorectal carcinoma. Cancer. 1998; 82: 632–8
   PubMed Web of Science ®Google Scholar
• Nathan FE, Hernandez E, Dunton CJ, Treat J, Switalska HI, Joseph RR, et al. Plasma thrombospondin levels in patients with gynecologic malignancies. Cancer. 1994; 73: 2853–8
   PubMed Web of Science ®Google Scholar
• Amenta PS, Martinez-Hernandez A, Trelstad RL. Repair and regeneration. Anderson's pathology10th edn, I Damjanov, J Linder. Mosby, St. Louis 1996; 2: 416–47
   Google Scholar
• Tuszynski GP, Kowalska MA, Karczewski J, Eichen J, Rothman VL, Capuzzi DM. Thrombospondin and VLDL promote platelet adhesion–-evidence for a common platelet adhesion receptor. Thromb Haemostas. 1989; 62: 418
   Google Scholar
• Tuszynski GP, Rothman VL, Murphy A, Siegler K, Knudsen KA. Thrombospondin promotes platelet aggregation. Blood. 1988; 72: 109–15
   PubMed Web of Science ®Google Scholar
• Wong SY, Purdie AT, Han P. Thrombospondin and other possible related matrix proteins in malignant and benign breast disease. Am J Pathol. 1992; 140: 1473–82
   PubMedGoogle Scholar
• Clezardin P, Frappart L, Clerget M, Pechoux C, Delmas PD. Expression of Thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast. Cancer Res. 1993; 53: 1421–30
   PubMed Web of Science ®Google Scholar
• Wang-Rodriguez J, Urquidi V, Rivard A, Goodison S. Elevated osteopontin and thrombospondin expression identifies malignant human breast carcinoma but is not indicative of metastatic status. Breast Cancer Res. 2003; 5: R136–43
   Google Scholar